John M. Maraganore

2009

In 2009, John M. Maraganore earned a total compensation of $1.5M as Chief Executive Officer at Alnylam Pharmaceuticals, a 39% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$86,625
Option Awards$924,483
Salary$525,000
Other$11,288
Total$1,547,396

Maraganore received $924.5K in option awards, accounting for 60% of the total pay in 2009.

Maraganore also received $86.6K in non-equity incentive plan, $525K in salary and $11.3K in other compensation.

Rankings

In 2009, John M. Maraganore's compensation ranked 3,086th out of 9,885 executives tracked by ExecPay. In other words, Maraganore earned more than 68.8% of executives.

ClassificationRankingPercentile
All
3,086
out of 9,885
69th
Division
Manufacturing
1,080
out of 3,690
71st
Major group
Chemicals And Allied Products
211
out of 866
76th
Industry group
Drugs
122
out of 638
81st
Industry
Pharmaceutical Preparations
99
out of 446
78th
Source: SEC filing on May 2, 2011.

Maraganore's colleagues

We found four more compensation records of executives who worked with John M. Maraganore at Alnylam Pharmaceuticals in 2009.

2009

Barry Greene

Alnylam Pharmaceuticals

Chief Operating Officer

2009

Akshay Vaishnaw

Alnylam Pharmaceuticals

Senior Vice President, Clinical Research

2009

John Schmidt

Alnylam Pharmaceuticals

Chief Scientific Officer

2009

Patricia Allen

Alnylam Pharmaceuticals

Vice President of Finance and Treasurer

News

In-depth

You may also like